ULMUS AMERICANA POLLEN: 66 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
66
Total FAERS Reports
0
Deaths Reported
3
Hospitalizations
66
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20150318 · Latest Report: 20231121
What Are the Most Common ULMUS AMERICANA POLLEN Side Effects?
#1 Most Reported
Anaphylactic reaction
19 reports (28.8%)
#2 Most Reported
Injection site erythema
10 reports (15.2%)
#3 Most Reported
Urticaria
9 reports (13.6%)
All ULMUS AMERICANA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 19 | 28.8% | 0 | 1 |
| Injection site erythema | 10 | 15.2% | 0 | 1 |
| Local reaction | 9 | 13.6% | 0 | 1 |
| Urticaria | 9 | 13.6% | 0 | 0 |
| Chest discomfort | 7 | 10.6% | 0 | 0 |
| Injection site reaction | 7 | 10.6% | 0 | 0 |
| Rash | 7 | 10.6% | 0 | 0 |
| Dyspnoea | 6 | 9.1% | 0 | 2 |
| Pruritus | 6 | 9.1% | 0 | 0 |
| False negative investigation result | 5 | 7.6% | 0 | 1 |
| Injection site swelling | 5 | 7.6% | 0 | 0 |
| Off label use | 5 | 7.6% | 0 | 0 |
| Wheezing | 5 | 7.6% | 0 | 0 |
Who Reports ULMUS AMERICANA POLLEN Side Effects? Age & Gender Data
Gender: 64.4% female, 35.6% male. Average age: 43.2 years. Most reports from: US. View detailed demographics →
Is ULMUS AMERICANA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 7 | 0 | 0 |
| 2016 | 9 | 0 | 0 |
| 2017 | 7 | 0 | 0 |
| 2018 | 3 | 0 | 0 |
| 2019 | 3 | 0 | 0 |
| 2020 | 5 | 0 | 1 |
| 2021 | 6 | 0 | 0 |
| 2022 | 6 | 0 | 1 |
| 2023 | 2 | 0 | 0 |
What Is ULMUS AMERICANA POLLEN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 10 |
| Skin test | 8 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for ULMUS AMERICANA POLLEN
Official prescribing information from the FDA-approved drug label.